As both CD44 and MMP2 are inducer of epithelial-mesenchymal-transition (EMT),which strengthens our confidence that WFCD2 might participate in tumor metastasis and disease processes by regulating the progression of EMT in ovarian cancer cells. This evidence concerns the gene CD44 and ovarian carcinoma.